In regenerative science, B7-33's potential to influence fibroblast activity and collagen turnover suggests possible implications for tissue repair and wound healing. Given that fibrosis is often a ...

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop.

Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery Utpal joins Zealand Pharma at a pivotal moment as it aims to become a leader in ...

The results Lilly is reporting for its oral pill come as another big drug company, Pfizer, has decided to discontinue its ...

Olon S.p.A. is honored to announce its receipt of the esteemed 2025 CMO Excellence in Green Chemistry Award. This accolade, conferred by the ACS Green Chemistry Institute Pharmaceutical Roundtable ...

Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path ...

Researchers have developed a pioneering, sustainable method for producing cadmium-based quantum dots (QDs) in water using a biocompatible chalcogen source. This fully aqueous, continuous flow process ...

Philipp Klahn, Senior Lecturer in Medicinal Chemistry and Chemical Biology Inspired by nature’s design, Philipp Klahn’s research focuses on the synthesis of bioactive molecules and drugs, with a ...

Fasting C-peptide (FCP) shows a nonlinear relationship with diabetic retinopathy (DR) risk, with a protective effect below 4.11 ng/mL. Above 4.11 ng/mL, the protective effect of FCP on DR becomes ...

This content is written in partnership with our chosen advertiser. To learn more click here Peptides are the buzzword of beauty right now. From promising plumped up skin to collagen-stimulating ...